Quick Answer
Oaktree Acquisition Corp. III Life Sciences reported Net Income of $7.29 million for fiscal year 2025.
Oaktree Acquisition Corp. III Life Sciences — Key Financials by Year
| Metric | 2025 | 2024 |
|---|---|---|
| Net Income | $7.29M | — |
| Total Assets | $203.11M +4.0% |
$195.25M |
| Cash and Equivalents | $1.43M +5.7% |
$1.36M |
| Stockholders Equity | -$6.77M | $0.00 |
| Operating Income | -$1.20M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | $1.97M | +4189.3% | +4.9% |
| Total Assets | September 30, 2025 | $201.25M | — | +1.0% |
| Cash and Equivalents | September 30, 2025 | $1.33M | — | -4.1% |
| Stockholders Equity | September 30, 2025 | -$6.76M | -29190.6% | -3.4% |
| Operating Income | September 30, 2025 | -$225.6K | -369.0% | +16.4% |
- Oaktree Acquisition Corp. III Life Sciences reported Net Income of $7.29 million for fiscal year 2025.
- Oaktree Acquisition Corp. III Life Sciences reported Total Assets of $203.11 million for fiscal year 2025.
- Oaktree Acquisition Corp. III Life Sciences showed an increase of +4.0% in Total Assets compared to the prior fiscal year.
- Oaktree Acquisition Corp. III Life Sciences reported Cash and Equivalents of $1.43 million for fiscal year 2025.
- Oaktree Acquisition Corp. III Life Sciences showed an increase of +5.7% in Cash and Equivalents compared to the prior fiscal year.
- Oaktree Acquisition Corp. III Life Sciences reported Stockholders Equity of -$6.77 million for fiscal year 2025.
- Oaktree Acquisition Corp. III Life Sciences showed a decrease of -11.5% in Stockholders Equity compared to the prior fiscal year.
- Oaktree Acquisition Corp. III Life Sciences reported Operating Income of -$1.20 million for fiscal year 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: